Share
NASDAQ
HCM
ADR/GDR
HUTCHMED (China) Limited
USD 10.1600
0.1700 (+1.7017%)
Last updated: 24 Jun 2026 5:02:50 PM
DelayedDelayed at least 15 minutes
Last updated: 24 Jun 2026 5:02:50 PM (Singapore Time)
NASDAQHCM ADR/GDR
HUTCHMED (China) Limited
DelayedDelayed at least 15 minutes
USD 10.1600
+1.7017%
+ USD 0.1700
Open
USD 9.9500
Prev. Close
USD 9.9900
Bid
USD 8.9100
Bid Volume
100
Ask
USD 11.6000
Ask Volume
200
Total Volume
22,772.441
9.9500
Day's Range
10.1700
9.7700
52 Weeks Range
19.5000
SHOW ALL KEY STATISTICS
HCM Chart
Delayed
Chart data is delayed at least 15 minutes.
3M 6M 1Y 3Y 5Y 10Y
TA Chart
Created with Highcharts 9.3.2Chart context menu30. Mar6. Apr13. Apr20. Apr27. Apr4. May11. May18. May25. May1. Jun8. Jun15. Jun22. Jun910111213141516fundsupermart.com
Stock Information
Market Cap
USD 1.75 billion
Share Outstanding
171.95 million
30 Days Average Volume
0.06 million
Product Currency
USD
Valuations
Earning Per Share
USD 2.650
Price-to-Earnings Ratio (PE)
3.770
Historical Avg. PE Ratio
-
Price-to-Book Ratio (PB)
1.388
Price-to-Sales Ratio (PS)
3.180
Price/Earnings-to-Growth Ratio
-
Selected Financial Data
Free Cash Flow
USD -88.81 million
Debt-to-Equity Ratio
0.057
Current Ratio
4.963
Quick Ratio
4.789
Return On Equity (%)
45.74
Return On Assets (%)
30.19
Dividend Info
Hist. Annual Dividend
-
Forward Div. Yield (%)
-
Pay-out Ratio (%)
-
Last Div. Ex Date
-
Next Div. Ex Date
-
Financial Information MORE
Created with Highcharts 9.3.2Chart context menuRevenueNet Income20252024202320222021-500.00M-250.00M0250.00M500.00M750.00M1000.00M
(USD)
2025 YOY Change
2024 YOY Change
2023 YOY Change
2022 YOY Change
2021 YOY Change
Revenue
548.51M
-12.96%
630.20M
-24.80%
838.00M
96.52%
426.41M
19.73%
356.13M
56.21%
Operating Income
-35.70M
-12.09%
-40.61M
-288.80%
21.51M
-105.28%
-407.69M
24.18%
-328.32M
66.94%
Net Income
456.91M
1,111.03%
37.73M
-62.56%
100.78M
-127.93%
-360.83M
85.38%
-194.65M
54.81%
About HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
Sector
Healthcare
Industry Classification
Drug Manufacturers - Specialty & Generic
Product Type
-
Sales
USD 548.51 million
Market Cap
USD 1.75 billion
Net Income
USD 456.91 million
Share Outstanding
171.95 million
Fiscal Year End
31 Dec 2026
52 Weeks Range
USD 9.7700 - USD 19.5000
Employees
1,796
30 Days Average Volume
0.06 million
Website
https://www.hutch-med.com
Payment Method
Included under Cash Yes
Included under CPFIS OA No
Included under CPFIS SA No
Included under SRS No
Upcoming Exchange Holidays MORE
United States (US)
02Jul
Independence Day (Observed)
06Sep
Labor Day
25Nov
Thanksgiving Day
26Nov
Day after Thanksgiving Day (Half-Day Trading)
23Dec
Day before Christmas Day (Half-Day Trading)
Tools
newCalculatorIcon
Stock Calculator
newCalculatorIcon
Stock Returns
newScreenerSelectorIcon
Stock Screener
newCalculatorIcon
Intrinsic Value Calculator
newGainerIcon
Top Gainer Loser